Latest Fludeoxyglucose Stories
BOSTON, Jan. 26 /PRNewswire/ -- FluoroPharma Inc., a company developing breakthrough molecular imaging agents for the Positron Emission Tomography (PET) market, announced today that the United States Patent and Trademark Office issued U.S. Patent No.
Controlled FDG Delivery Study Uses Intego(TM) PET Infusion System to Compare Techniques for Patient Management WARRENDALE, Pa., Jan.
HOUSTON, Oct. 17 /PRNewswire-USNewswire/ -- Early in 2008, the National Oncologic PET Registry (NOPR) published its initial results indicating that clinicians changed the intended care of more than one in three cancer patients as the result of FDG-PET scan findings.
By Herrmann, Ken Eckel, Florian; Schmidt, Stefan; Scheidhauer, Klemens; Krause, Bernd Joachim; Kleeff, Joerg; Schuster, Tibor; Wester, Hans- Juergen; Friess, Helmut; Schmid, Roland M; Schwaiger, Markus; Buck, Andreas K We have determined the ability of PET with the thymidine analog 3'-deoxy-3'-^sup 18^F-fluorothymidine (FLT) to detect pancreatic cancer and to differentiate malignant from benign pancreatic lesions.
IBA (Ion Beam Applications S.A.: Reuters IBAB.BR and Bloomberg IBAB.BB) the leading global provider of PET radiopharmaceuticals, and NST (NeuroSurvival Technologies Ltd.) the leading developer of agents targeting apoptosis (programmed cell death) for molecular imaging and therapy, today announced the signing of a collaboration agreement for radiolabeling and distributing APOSENSE(R) [18F]-ML-10, NST's novel agent for molecular imaging of apoptosis, to sites participating in multi-center...
KENNEWICK, Wash., Aug.
QuantRx Biomedical has announced that the company's FluoroPharma has achieved positive Phase I results for BFPET, its novel Fluorine-18 labeled tracer for myocardial perfusion imaging.
CALGARY, ALBERTA--(Marketwire - June 30, 2008) - Fording Canadian Coal Trust (TSX:FDG.UN) (NYSE:FDG) will release its 2008 second quarter financial results on Wednesday, July 23, 2008 following the close of markets.
By Plathow, Christian Weber, Wolfgang A Molecular imaging of tumor metabolism has gained considerable interest, since preclinical studies have indicated a close relationship between the activation of various oncogenes and alterations of cellular metabolism.
By Tumeh, Paul C Radu, Caius G; Ribas, Antoni Immune system activation can be elicited in viral infections, active immunization, or cancer immunotherapy, leading to the final common phenotype of increased glycolytic use by immune cells and subsequent detection by ^sup 18^F-FDG PET.